MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-50-0011822
Newmet Pharmaceuticals Private Limited
Newmet Pharmaceuticals Private Limited - pharma in Ghaziabad, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹2.36 Cr
▲ 11% YoY
Net profit · FY 2025
₹8.84 Lakh
Net margin 3.7%
EBITDA · FY 2025
₹14.82 Lakh
EBITDA margin 6.3%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹6 Lakh
Issued & subscribed
Open charges
₹50 Lakh
Secured borrowings
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
About Newmet Pharmaceuticals Private Limited
Data last updated:
Newmet Pharmaceuticals Private Limited is a private limited company based in Ghaziabad, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 02 December 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24304UP2016PTC088075. Its GSTIN is 09AAFCN4287L1ZU (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹6 Lakh. It is led by directors Sonu Singh and Dolly Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1649 Bhagirathi Tower Mahagun Puram, Ghaziabad, Uttar Pradesh, India – 201010.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.36 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹8.84 Lakh (net margin 3.7%) and EBITDA of ₹14.82 Lakh (EBITDA margin 6.3%). Revenue has grown at a compounded annual rate (CAGR) of 36% over three years and 47% over five years.
As per MCA filings, the company has open charges of ₹50 Lakh on record. Court records list 4 cases involving the company, including 4 filed against it; 4 cases are pending.
Newmet Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-50-0011822). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24304UP2016PTC088075
Registration Number 088075
Incorporation Date 02 December 2016
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-50-0011822
Recognitions & Rankings of Newmet Pharmaceuticals
Contact details
Newmet Pharmaceuticals Private Limited's registered office is in Ghaziabad, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address1649 Bhagirathi Tower Mahagun Puram, Ghaziabad, Uttar Pradesh, India – 201010
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Newmet Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Newmet Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Newmet Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Newmet Pharmaceuticals Private Limited, buy the company report.
Financials of Newmet Pharmaceuticals Private Limited
FY 2025 filings availableNewmet Pharmaceuticals Private Limited reported revenue of ₹2.36 Cr (up 11% YoY) for FY 2025.
Revenue · FY 2025
₹2.36 Cr ▲ 11%
Net profit · FY 2025
₹8.84 Lakh margin 3.7%
EBITDA · FY 2025
₹14.82 Lakh margin 6.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 36%
5 years · compounded
▲ 47%
EBITDA CAGR growth
1 year
▼ 2%
3 years · compounded
▲ 64%
5 years · compounded
▲ 64%
Revenue has grown at a compounded annual rate (CAGR) of 47% over five years, including 11% growth in the latest year. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14.82 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.84 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.3% | ||||
| Net Profit Margin | 3.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Newmet Pharmaceuticals Private Limited, buy the company report.
Board of directors of Newmet Pharmaceuticals Private Limited
Newmet Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sonu Singh | Additional Director | 15 May 2019 | 7 Years 5 Months | Current |
| Dolly Singh | Additional Director | 15 May 2019 | 7 Years 5 Months | Current |
Peer comparison
Newmet Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Wagnerhuber Pharmaceuticals Private Limited | ₹2.36 Cr (FY 2025) | -8.0% | Chandigarh, India | |||
| Newmet Pharmaceuticals Private Limitedthis company | ₹2.36 Cr (FY 2025) | ₹8.84 Lakh | 3.7% | 11.0% | Ghaziabad, Uttar Pradesh, India | |
| Quality Innovations and Pharmaceuticals India Private Limited | ₹2.36 Cr (FY 2025) | 0.0% | Thiruvananthapuram, Kerala, India | |||
| Saphire Biotech Private Limited | ₹2.36 Cr (FY 2024) | 14.0% | Bhopal, Madhya Pradesh, India | |||
| Jeevan Raksha Aushadi Private Limited | ₹2.36 Cr (FY 2024) | 73.0% | Delhi, India |
To see the full peer comparison of Newmet Pharmaceuticals Private Limited, buy the company report.
Auditor
Newmet Pharmaceuticals Private Limited is audited by PRABODH PATODIA & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PRABODH PATODIA & CO. | FY 2017 | 014012C |
Shareholding
The shareholding of Newmet Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Newmet Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹50 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Feb 2024 | 100888658 | Indian Bank | ₹50 Lakh | Open |
To see the full charge records of Newmet Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Newmet Pharmaceuticals Private Limited has 4 court cases on record: 4 filed against it. All cases are pending.
Total cases
4
Filed against the company
4
Pending
4
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 4 | 4 |
Cases on record (1 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Lucknow, Uttar Pradesh | Criminal case | Filed against the company by State of Up | Pending |
To see the full case history of Newmet Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Newmet Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Newmet Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAFCN4287L1ZU | Uttar Pradesh | Active | 23 Feb 2018 |
To see the full GST registrations and return filing status of Newmet Pharmaceuticals Private Limited, buy the company report.
Recent activity
Newmet Pharmaceuticals Private Limited has 4 board changes on record since 2019: 2 appointments and 2 cessations. The latest: Dolly Singh was appointed as Additional Director on 15 May 2019.
AGM
Newmet Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Newmet Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh Ii.
Charges
A charge with Indian Bank of Rs. 50.00 Lakh registered on 26 Feb 2024 with Charge ID 100888658 was modified on 12 Mar 2025.
Charges
A charge with Indian Bank amounted to Rs. 50.00 Lakh with Charge ID 100888658 was registered on 26 Feb 2024.
Appointed
Dolly Singh was appointed as Additional Director.
Ceased
Hemendra Kumar Singh ceased to be Director.
Appointed
Sonu Singh was appointed as Additional Director.
Ceased
Vinay Kumar Singh ceased to be Director.
Incorporation
02 Dec 2016
Newmet Pharmaceuticals Private Limited was registered on 02 Dec 2016 with Roc Uttar Pradesh Ii & aged 9 years 11 months as per MCA records.
Frequently asked questions
Newmet Pharmaceuticals is an active private limited company based in Ghaziabad, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 02 December 2016 (10+ years old) and is registered under CIN U24304UP2016PTC088075.
Newmet Pharmaceuticals has 2 current directors:
- Sonu Singh - Additional Director
- Dolly Singh - Additional Director
The latest financial statements of Newmet Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Newmet Pharmaceuticals is 09AAFCN4287L1ZU, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Newmet Pharmaceuticals is U24304UP2016PTC088075. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Newmet Pharmaceuticals has 4 court cases on record: 4 filed against it. 4 are pending.
Newmet Pharmaceuticals was incorporated on 02 December 2016, making it 10+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Newmet Pharmaceuticals by revenue are Wagnerhuber Pharmaceuticals Private Limited, Quality Innovations and Pharmaceuticals India Private Limited, Saphire Biotech Private Limited, Jeevan Raksha Aushadi Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Dolly Singh was appointed as Additional Director on 15 May 2019. Hemendra Kumar Singh ceased to be Director on 15 May 2019. Sonu Singh was appointed as Additional Director on 15 May 2019. Newmet Pharmaceuticals has 4 board changes on record in total.
Yes, Newmet Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-50-0011822).
The registered office of Newmet Pharmaceuticals is at 1649 Bhagirathi Tower Mahagun Puram, Ghaziabad, Uttar Pradesh, India – 201010.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages